Icosagen Cell Factory

Icosagen is a privately held, revenue-generating CRDMO based in Tartu, Estonia, with over two decades of experience in biologics development. The company leverages its proprietary Quadroma-based Mouse Cell Fusion (Q-MCF®) technology and mammalian expression platforms to offer a full spectrum of services from antibody discovery to GMP manufacturing. It has established a strong reputation for technical expertise, flexibility, and client-centric project management, serving a global clientele of biotech, pharma, and academic institutions. Its integrated model as a combined CRO and CDMO allows it to capture value across the entire biologics development lifecycle.

Proprietary Quadroma-based Mouse Cell Fusion (Q-MCF®) for antibody discovery, mammalian expression systems (CHO/HEK), cell line development, and integrated downstream processing & GMP manufacturing.

Competes with large global CDMOs (e.g., Lonza, Samsung Biologics) and specialized antibody CROs. Differentiation is based on integrated end-to-end services, proprietary discovery technology (Q-MCF®), flexibility, and a strong reputation for handling complex projects in a collaborative manner.